Patents by Inventor Jared Robert
Jared Robert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250122580Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: ApplicationFiled: October 30, 2024Publication date: April 17, 2025Applicant: MYRIAD WOMEN'S HEALTH, INC.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Patent number: 12270082Abstract: The present disclosure relates to methods for detecting unique genetic signatures derived from markers such as, for example, mutations, somatic or germ-line, in nucleic acids obtained from biological samples. The sensitivity of the methods provides for detection of mutations associated with a disease, e.g., cancer mutations, or with inherited disease, e.g., an autosomal recessive disease, in a noninvasive manner at ultra-low proportions of sequences carrying mutations to sequences carrying normal, e.g., non-cancer sequences, or a reference sequence, e.g., a human reference genome.Type: GrantFiled: February 23, 2022Date of Patent: April 8, 2025Assignee: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Publication number: 20250066862Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: ApplicationFiled: September 5, 2024Publication date: February 27, 2025Applicant: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Patent number: 12232456Abstract: Methods and systems for hydration of plants are provided. An example method includes generating structurally altered gas molecules from water. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into water. The method further includes providing the water infused by the structurally altered gas molecules to a plant. The structurally altered gas molecules cause improvement of at least one characteristic concerning growing of the plant.Type: GrantFiled: October 4, 2023Date of Patent: February 25, 2025Assignee: H2Plus LLCInventors: Gene Dedick, Jared Roberts
-
Patent number: 12215392Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: GrantFiled: April 11, 2024Date of Patent: February 4, 2025Assignee: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Patent number: 12215391Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: GrantFiled: July 24, 2023Date of Patent: February 4, 2025Assignee: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Publication number: 20250034647Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: ApplicationFiled: July 24, 2023Publication date: January 30, 2025Applicant: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Patent number: 12129345Abstract: Methods and systems for degradation of polymeric substances is provided. An example method includes generating structurally altered gas molecules from water, where the structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a matter containing the polymeric substances, where upon being infused, the structurally altered gas molecules cause a decrease in concentration of the polymeric substances in the matter.Type: GrantFiled: October 4, 2023Date of Patent: October 29, 2024Assignees: H2 Plus LLC, H2Plus Operations, LLCInventors: Gene Dedick, Jared Roberts
-
Publication number: 20240355461Abstract: A healthcare management system is described. The system may include one or more nodes associated with a blockchain. The one or more nodes may include a blockchain ledger having patient information. The nodes may further include a processor configured to obtain a request from a patient to avail a medical procedure from a medical provider. The processor may obtain the patient information from the blockchain ledger responsive to obtaining the request. The processor may determine that a health saving account associated with the patient is linked with healthcare management system, and schedule an appointment for the medical procedure with the medical provider when the health saving account is linked with the system. In addition, the processor may determine a medical procedure authenticity, and deduct an amount associated with the medical procedure from the health saving account responsive to a determination that the medical procedure is authentic.Type: ApplicationFiled: April 24, 2023Publication date: October 24, 2024Applicant: Smile Bridge, LLCInventor: Jared Robert Burr
-
Publication number: 20240352511Abstract: A method of identifying and quantifying copy number variations in a gene of interest for a genomic DNA sample includes (i) fragmenting a genomic DNA sample to produce a plurality of polynucleotide fragments, (ii) isolating a plurality of target polynucleotide fragments, (iii) sequencing the plurality of target polynucleotide fragments, (iv) aligning fragment sequences to a reference sequence, (v) calculating read depths for base positions of the plurality of target polynucleotide fragments, (vi) calculating copy number likelihoods for each base position of the reference sequence, (vii) performing a breakpoint analysis on a set of fragment sequences to identify at least one sequence variation located between selected breakpoint regions of the target gene and calculate modified copy number likelihoods for base positions of the reference sequence based on the at least one sequence variation, and (viii) determining whether the target gene includes at least one copy number variation.Type: ApplicationFiled: April 17, 2024Publication date: October 24, 2024Applicant: MYRIAD WOMEN'S HEALTH, INC.Inventors: Jared Robert Maguire, Alexander D. Robertson, Eric Andrew Evans
-
Patent number: 12122969Abstract: Methods and systems for fuel treatment are provided. An example method includes generating structurally altered gas molecules from water. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a fuel to modify properties of the fuel, thereby increasing fuel burning efficiency.Type: GrantFiled: October 4, 2023Date of Patent: October 22, 2024Assignee: H2Plus LLCInventors: Gene Dedick, Jared Roberts
-
Patent number: 12104212Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: GrantFiled: November 8, 2023Date of Patent: October 1, 2024Assignee: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Publication number: 20240294990Abstract: The present disclosure relates to methods for detecting unique genetic signatures derived from markers such as, for example, mutations, somatic or germ-line, in nucleic acids obtained from biological samples. The sensitivity of the methods provides for detection of mutations associated with a disease, e.g., cancer mutations, or with inherited disease, e.g., an autosomal recessive disease, in a noninvasive manner at ultra-low proportions of sequences carrying mutations to sequences carrying normal, e.g., non-cancer sequences, or a reference sequence, e.g., a human reference genome.Type: ApplicationFiled: May 15, 2024Publication date: September 5, 2024Applicant: MYRIAD WOMEN'S HEALTH, INC.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Publication number: 20240271224Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: ApplicationFiled: April 11, 2024Publication date: August 15, 2024Applicant: MYRIAD WOMEN'S HEALTH, INC.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Patent number: 12024749Abstract: The present disclosure relates to methods for detecting unique genetic signatures derived from markers such as, for example, mutations, somatic or germ-line, in nucleic acids obtained from biological samples. The sensitivity of the methods provides for detection of mutations associated with a disease, e.g., cancer mutations, or with inherited disease, e.g., an autosomal recessive disease, in a noninvasive manner at ultra-low proportions of sequences carrying mutations to sequences carrying normal, e.g., non-cancer sequences, or a reference sequence, e.g., a human reference genome.Type: GrantFiled: February 7, 2020Date of Patent: July 2, 2024Assignee: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker
-
Patent number: 12018391Abstract: Methods and systems for generation and deployment of a structurally altered gas molecules derived from water are provided. An example system includes a first container for combining purified water with a compound mixture being non-reactive with the water and a conductor of an electric field and a magnetic field. The system includes a magnetic field generator and an electric field generator designed to apply the magnetic field and the electric field to the combination of the purified water and the compound mixture to cause generation of the structurally altered gas molecules having a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the purified water. The system further includes a second container for introducing the structurally altered gas molecules into an environment of a chemical process to facilitate electron transfers during the chemical process, thereby increasing output of the chemical process.Type: GrantFiled: November 23, 2023Date of Patent: June 25, 2024Assignees: H2Plus LLC Operations, LLC, H2Plus Operations, LLCInventors: Gene Dedick, Gustav Eriksson, Jared Roberts, David Hauschild
-
Patent number: 12000053Abstract: Methods and systems for generation and deployment of a structurally altered gas molecules derived from water are provided. An example method includes combining purified water with a compound mixture. The compound mixture is non-reactive with the water and a conductor of an electric field and a magnetic field. The method includes applying the magnetic field and the electric field to the combination of the purified water and the compound mixture to cause generation of the structurally altered gas molecules. The structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the purified water. The method further includes introducing the structurally altered gas molecules into an environment of a chemical process. The structurally altered gas molecules facilitate electron transfers during the chemical process, thereby increasing output of the chemical process.Type: GrantFiled: October 4, 2023Date of Patent: June 4, 2024Assignees: H2Plus LLC, H2Plus Operations, LLCInventors: Gene Dedick, Gustav Eriksson, Jared Roberts, David Hauschild
-
Patent number: 11993683Abstract: Methods and systems for degradation of polymeric and non-polymeric substances is provided. An example method includes generating structurally altered gas molecules from water, where the structurally altered gas molecules have a higher probability of attraction of electrons into areas adjunct to the structurally altered gas molecules than molecules of the water. The method further includes infusing the structurally altered gas molecules into a matter containing the polymeric substances and the non-polymeric substances, where upon being infused, the structurally altered gas molecules cause a decrease in concentration of the polymeric substances and the non-polymeric substances in the matter.Type: GrantFiled: December 8, 2023Date of Patent: May 28, 2024Assignees: H2PLUS LLC, H2Plus Operations, LLCInventors: Gene Dedick, Jared Roberts
-
Patent number: 11993811Abstract: A method of identifying and quantifying copy number variations in a gene of interest for a genomic DNA sample includes (i) fragmenting a genomic DNA sample to produce a plurality of polynucleotide fragments, (ii) isolating a plurality of target polynucleotide fragments, (iii) sequencing the plurality of target polynucleotide fragments, (iv) aligning fragment sequences to a reference sequence, (v) calculating read depths for base positions of the plurality of target polynucleotide fragments, (vi) calculating copy number likelihoods for each base position of the reference sequence, (vii) performing a breakpoint analysis on a set of fragment sequences to identify at least one sequence variation located between selected breakpoint regions of the target gene and calculate modified copy number likelihoods for base positions of the reference sequence based on the at least one sequence variation, and (viii) determining whether the target gene includes at least one copy number variation.Type: GrantFiled: January 30, 2018Date of Patent: May 28, 2024Assignee: Myriad Women's Health, Inc.Inventors: Jared Robert Maguire, Alexander D. Robertson, Eric Andrew Evans
-
Publication number: 20240150846Abstract: The present disclosure relates to a laboratory execution system that provides for automation of laboratory processes. A centralized data management system may be dynamically updated and used to facilitate management of components of the laboratory execution system, such as an automation system and an analytics results management system that may facilitate complex analytical functions, such as synthesizing raw test data. Potential workflows include the detection of specific molecules of interest.Type: ApplicationFiled: January 11, 2024Publication date: May 9, 2024Applicant: MYRIAD WOMEN'S HEALTH, INC.Inventors: Jared Robert Maguire, Clement S. Chu, Imran Saeedul Haque, Eric Andrew Evans, Noah Welker